TY - JOUR
T1 - The phenotypic spectrum of PCDH12 associated disorders - Five new cases and review of the literature
AU - Fazeli, Walid
AU - Bamborschke, Daniel
AU - Moawia, Abubakar
AU - Bakhtiari, Somayeh
AU - Tafakhori, Abbas
AU - Giersdorf, Matthias
AU - Hahn, Andreas
AU - Weik, Anja
AU - Kolzter, Kirsten
AU - Shafiee, Sajad
AU - Jin, Sheng Chih
AU - Körber, Friederike
AU - Lee-Kirsch, Min Ae
AU - Darvish, Hossein
AU - Cirak, Sebahattin
AU - Kruer, Michael C.
AU - Koy, Anne
N1 - Publisher Copyright:
© 2021 European Paediatric Neurology Society
PY - 2022/1
Y1 - 2022/1
N2 - PCDH12 is a member of the non-clustered protocadherin family of calcium-dependent cell adhesion proteins, which are involved in the regulation of brain development and endothelial adhesion. To date, only 15 families have been reported with PCDH12 associated disease. The main features previously associated with PCDH12 deficiency are developmental delay, movement disorder, epilepsy, microcephaly, visual impairment, midbrain malformations, and intracranial calcifications. Here, we report novel clinical features such as onset of epilepsy after infancy, episodes of transient developmental regression, and dysplasia of the medulla oblongata associated with three different novel truncating PCDH12 mutations in five cases (three children, two adults) from three unrelated families. Interestingly, our data suggests a clinical overlap with interferonopathies, and we show an elevated interferon score in two pediatric patients. This case series expands the genetic and phenotypic spectrum of PCDH12 associated diseases and highlights the broad clinical variability.
AB - PCDH12 is a member of the non-clustered protocadherin family of calcium-dependent cell adhesion proteins, which are involved in the regulation of brain development and endothelial adhesion. To date, only 15 families have been reported with PCDH12 associated disease. The main features previously associated with PCDH12 deficiency are developmental delay, movement disorder, epilepsy, microcephaly, visual impairment, midbrain malformations, and intracranial calcifications. Here, we report novel clinical features such as onset of epilepsy after infancy, episodes of transient developmental regression, and dysplasia of the medulla oblongata associated with three different novel truncating PCDH12 mutations in five cases (three children, two adults) from three unrelated families. Interestingly, our data suggests a clinical overlap with interferonopathies, and we show an elevated interferon score in two pediatric patients. This case series expands the genetic and phenotypic spectrum of PCDH12 associated diseases and highlights the broad clinical variability.
KW - Brain malformation
KW - Epilepsy
KW - Interferonopathy
KW - Intracranial calcification
KW - Movement disorder
KW - PCDH12
UR - http://www.scopus.com/inward/record.url?scp=85118885945&partnerID=8YFLogxK
U2 - 10.1016/j.ejpn.2021.10.011
DO - 10.1016/j.ejpn.2021.10.011
M3 - Article
C2 - 34773825
AN - SCOPUS:85118885945
SN - 1090-3798
VL - 36
SP - 7
EP - 13
JO - European Journal of Paediatric Neurology
JF - European Journal of Paediatric Neurology
ER -